Categories Biosimilars -Adelphi Values

Biosimilars

Payer value slide deck for a biosimilar in diabetes
Budget impact models for a biosimilar in type 1 and type 2 diabetes mellitus
Global value dossier, AMCP and accompanying slide sets for an insulin biosimilar

Payer value slides for immunology biosimilars
Frequently asked questions to support the introduction of a new biosimilar in immunology
Frequently asked questions for biosimilar policy in immunology
Frequently asked questions on an immunology biosimilar for rheumatoid arthritis
Budget impact model for a biosimilar
Literature review and update to budget impact model in an immunology biosimilar
Updates to a US budget impact model for an immunology biosimilar
Update to an AMCP dossier for an immunology biosimilar
Originator vs. biosimilar value proposition update in immunology
Updates to a global value dossier, AMCP dossier and budget impact model on a rheumatoid arthritis biosimilar
Structured literature review and value dossier updates in a biosimilar for axial spondyloarthiritis, Crohn’s disease, hidradenitis suppurativa, juvenile idiopathic arthritis, paediatric Crohn’s disease, paediatric plaque psoriasis, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis and uveitis
Budget impact model on a biosimilar in multiple immunology indications

Burden of disease deck and frequently asked questions deck in breast cancer biosimilars
Development of a cost-calculator for a biosimilar for breast and gastric cancer
One-pager communication in a breast cancer biosimilar
Payer value deck update for a breast cancer biosimilar
Response to payer questions update for a breast cancer biosimilar
Budget impact model for a biosimilar in HER2 breast cancer
Budget impact model on an oncology biosimilar
Budget impact model for a biosimilar in multiple oncology indications

Development of a value dossier, health economic model and literature review in an infertility biosimilar to support pricing and reimbursement submissions in 15 EU countries
Pricing updates in Europe for a biosimilar hormone treatment for female infertility

Global value and reimbursement dossier for a biosimilar in autoimmune disease
Biosimilar payer communications in dermatology, gastroenterology and immunology
Global value dossiers and budget impact models for biosimilars in ankylosing spondylitis, Crohn’s disease, inflammatory bowel disease (IBD), osteoarthritis, psoriasis and rheumatoid arthritis
Manuscript on a budget impact model for a biosimilar in haematology and rheumatology